Navigation Links
Europe spends nearly twice as much as US on nanotech risk research

Washington, DC A new analysis by the Project on Emerging Nanotechnologies (PEN) indicates that European nations are investing nearly twice as much as the U.S. in research primarily aimed at addressing the potential risks of nanotechnology. The analysis also highlights a substantial over-inflation of the federal governments nanotechnology risk-research investment figures for the U.S.

The new PEN assessment of nanotechnology risk-relevant projects identified by the federal governments National Nanotechnology Initiative (NNI) for fiscal year 2006 found that only $13 million was invested in projects highly relevant to addressing possible risks.

Over the same time period, the PEN analysis found European countries invested nearly $24 million in projects with the primary aim of addressing nanotechnology risks.

PEN evaluated research projects listed in the NNI research strategyreleased in February 2008 but without specifics regarding the annual project budget or the applicability of each project to assessing potential hazardsby their relevance to addressing current and future nanotechnology risks. Research was classified according to whether it was highly relevant to addressing potential environment, health or safety hazards, substantially relevant, having some relevance, or was only marginally relevant.

By collecting individual project budget data from publicly available sources, an estimate was made of funding levels for 2006. The assessment found 62 federally-funded projects that were highly relevant to understanding nanotechnology risk, with an estimated annual budget of $13 million.

In contrast, the federal government estimates $37.7 million was invested in highly relevant research in fiscal year 2006. According to PEN Chief Science Advisor Andrew Maynard, It appears the U.S. is guilty of wishful thinking in its assessment of research that will lead to the development of safe nanotechnologies. It is trying to substitute research that might inform sciences general understanding of possible nanotechnology risks for research that is focused on getting answers to direct questions being asked todaywhat makes a nanomaterial potentially harmful, how can it be used safely, and what happens when it is eventually disposed" Both the U.S. government figure and the results of the PEN assessment show that less than 3 percent of the $1.4 billion federal nanotechnology research budget was spent on environment, health and safety research.

Draft legislation proposed by U.S. House of Representatives Science Committee Chair Bart Gordon (D-TN) would amend the NNI act to include a minimum 10 percent mandate for the nanotechnology federal research and development budget devoted to EHS research in the future, amounting to approximately $150 million annually.


Contact: Julia Moore
Project on Emerging Nanotechnologies

Related biology technology :

1. DuoCort Hosts Adrenal Insufficiency Symposium at the 10th European Congress of Endocrinology in Berlin
2. Squire Sanders Stands Out in Independent Analysis of Law Firms in Europe
3. High-Definition Technology to Revolutionize US & European Visualization Device Markets
4. Arbios Commences Process to Seek European Marketing Approval for SEPET(TM)
5. Cephalon Announces European Commission Approval of EFFENTORA for the Treatment of Breakthrough Cancer Pain
6. Intellect Neurosciences, Inc. Receives Notice of Allowance and Completes Grant Requirements for Pivotal European Patent Related to Passive Immunization of Alzheimers Disease
7. MaxCyte to Present at BIO-Europe Spring 2008 Conference
8. Cardiums InnerCool Therapies Unit Announces European Commercialization Agreement for Portfolio of Temperature Modulation Systems
9. Tengion Announces European Orphan Drug Designation for Neo-Bladder Augment
10. Volcano Announces U.S. and European Launch of Rotational IVUS and Integrated FFR
11. Campbell Alliance Sales Practice to Conduct Workshop at EyeForPharma SFE Europe Conference
Post Your Comments:
(Date:11/26/2015)... CHESHAM , England , November 26, ... Lightpoint Medical, an innovative medical device company specializing in ... Euro grant from the European Commission as part of the ... enabling the company to carry out a large-scale clinical trial ... -->      (Logo: , ...
(Date:11/25/2015)... Nov. 25, 2015  PharmAthene, Inc. (NYSE MKT: PIP) ... a stockholder rights plan (Rights Plan) in an effort ... carryforwards (NOLs) under Section 382 of the Internal Revenue ... PharmAthene,s use of its NOLs could be substantially ... defined in Section 382 of the Code. In general, ...
(Date:11/25/2015)... -- Studies reveal the differences in species ... the way for more effective treatment for one of the ... --> --> Gum disease ... cats, yet relatively little was understood about the bacteria associated ... conducted by researchers from the WALTHAM Centre for Pet Nutrition ...
(Date:11/25/2015)... 2015  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) ... CEO of Neurocrine Biosciences, will be presenting at the ... New York . .   ... 5 minutes prior to the presentation to download or ... will be available on the website approximately one hour ...
Breaking Biology Technology:
(Date:11/16/2015)... Calif. , Nov 16, 2015  Synaptics ... of human interface solutions, today announced expansion of ... TouchView ™ touch controller and display driver ... revolution of smartphones. These new TDDI products add ... TD4100 (HD resolution), TD4302 (WQHD resolution), and TD4322 ...
(Date:11/10/2015)... , Nov. 10, 2015  In this ... the basis of product, type, application, disease ... in this report are consumables, services, software. ... are safety biomarkers, efficacy biomarkers, and validation ... report are diagnostics development, drug discovery and ...
(Date:11/2/2015)... Nov. 2, 2015  SRI International has been awarded ... preclinical development services to the National Cancer Institute (NCI) ... provide scientific expertise, modern testing and support facilities, and ... pharmacology and toxicology studies to evaluate potential cancer prevention ... The PREVENT Cancer Drug Development Program is an NCI-supported ...
Breaking Biology News(10 mins):